Join Growin Stock Community!

Nexalin technology, inc.NXL.US Overview

US StockHealthcare
(No presentation for NXL)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

NXL AI Insights

NXL Overall Performance

NXL AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

NXL Recent Performance

-5.29%

Nexalin technology, inc.

-3.61%

Avg of Sector

-2.16%

S&P500

NXL PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

NXL Key Information

NXL Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

NXL Profile

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.

Price of NXL

NXL FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

NXL Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.47
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
55.86
PB Ratio
2.04
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
69.52%
Net Margin
-5530.40%
Revenue Growth (YoY)
-3.18%
Profit Growth (YoY)
-14.61%
3-Year Revenue Growth
-67.83%
3-Year Profit Growth
-65.90%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.47
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
55.86
PB Ratio
2.04
Price-to-FCF
-
Gross Margin
69.52%
Net Margin
-5530.40%
Revenue Growth (YoY)
-3.18%
Profit Growth (YoY)
-14.61%
3-Year Revenue Growth
-67.83%
3-Year Profit Growth
-65.90%
  • When is NXL's latest earnings report released?

    The most recent financial report for Nexalin technology, inc. (NXL) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating NXL's short-term business performance and financial health. For the latest updates on NXL's earnings releases, visit this page regularly.

  • What is the operating profit of NXL?

    According to the latest financial report, Nexalin technology, inc. (NXL) reported an Operating Profit of -2.35M with an Operating Margin of -12,924.3% this period, representing a growth of 6.49% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is NXL's revenue growth?

    In the latest financial report, Nexalin technology, inc. (NXL) announced revenue of 18.15K, with a Year-Over-Year growth rate of -49.63%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does NXL have?

    At the end of the period, Nexalin technology, inc. (NXL) held Total Cash and Cash Equivalents of 590.08K, accounting for 0.12 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does NXL go with three margins increasing?

    In the latest report, Nexalin technology, inc. (NXL) did not achieve the “three margins increasing” benchmark, with a gross margin of 78.2%%, operating margin of -12,924.3%%, and net margin of -12,542.3%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess NXL's profit trajectory and future growth potential.

  • Is NXL's EPS continuing to grow?

    According to the past four quarterly reports, Nexalin technology, inc. (NXL)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.13. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of NXL?

    Nexalin technology, inc. (NXL)'s Free Cash Flow (FCF) for the period is -1.47M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 83.23% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.